Prescription drug · ANDA
Oxybutynin Chloride NDC 71610-394
Oxybutynin chloride 5 mg/1 · Tablet · Oral · Aphena Pharma Solutions - Tennessee, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71610-394-53 | 7161003945371610039453 | 60 TABLET in 1 BOTTLE, PLASTIC (71610-394-53)Marketed from Feb 5, 2020 | |
| 71610-394-60 | 7161003946071610039460 | 90 TABLET in 1 BOTTLE, PLASTIC (71610-394-60)Marketed from Feb 5, 2020 | |
| 71610-394-80 | 7161003948071610039480 | 180 TABLET in 1 BOTTLE, PLASTIC (71610-394-80)Marketed from Dec 30, 2022 | |
| 71610-394-92 | 7161003949271610039492 | 270 TABLET in 1 BOTTLE, PLASTIC (71610-394-92)Marketed from Feb 5, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Oxybutynin Chloride
- Generic name (nonproprietary)
- oxybutynin chloride
- Active ingredients
- Oxybutynin chloride — 5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Aphena Pharma Solutions - Tennessee, LLCNDC labeler code 71610
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 210125
- Marketing start
- Listing expires
- Other FDA classes
- Cholinergic Muscarinic Antagonists (Mechanism)
- Identifiers
- Product ID 71610-394_7dee4b0d-3071-4962-82b6-0b0ff220f91aSPL ID 7dee4b0d-3071-4962-82b6-0b0ff220f91aSPL set ID 1e1c1043-e4c5-4a06-9cc1-45d4397746f4RxCUI 863664UNII L9F3D9RENQ
- Pharmacologic class
- Cholinergic Muscarinic Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471610039453followed by a unit qualifier and the quantityPackage 71610-0394-53. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Oxybutynin chloride tablets are indicated for the relief of symptoms of bladder instability associated with voiding in patients with uninhibited neurogenic or reflex neurogenic bladder (i.e., urgency, frequency, urinary leakage, urge incontinence, dysuria).
Excerpt only. Read the full label for complete information.
About NDC 71610-394
- What is NDC 71610-394?
- 71610-394 is the product NDC for Oxybutynin Chloride, Oxybutynin chloride 5 mg/1 tablet, listed with the FDA by Aphena Pharma Solutions - Tennessee, LLC. It has 4 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Oxybutynin Chloride.
- What is the active ingredient?
- Oxybutynin chloride.
- Who is the labeler?
- Aphena Pharma Solutions - Tennessee, LLC, NDC labeler code 71610. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Oxybutynin Chloride?
- 79 other product NDCs are listed under this name. See all Oxybutynin Chloride NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Oxybutynin Chloride products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Oxybutynin Chloride | Oxybutynin chloride 2.5 mg/1 | TabletOral | TruPharma LLC | 52817-261 | 52817-0261-10 |
| Oxybutynin Chloride | Oxybutynin chloride 2.5 mg/1 | TabletOral | RISING PHARMA HOLDINGS, INC. | 64980-734 | 64980-0734-01 |
| Oxybutynin Chloride | Oxybutynin chloride 5 mg/1 | TabletOral | Coupler LLC | 67046-1381 | 67046-1381-03 |
| Oxybutynin Chloride | Oxybutynin chloride 5 mg/1 | TabletOral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-913 | 23155-0913-0123155-0913-0523155-0913-10 |
| Oxybutynin Chloride | Oxybutynin chloride 5 mg/1 | TabletOral | RISING PHARMA HOLDINGS, INC. | 64980-679 | 64980-0679-0164980-0679-1064980-0679-50 |
| Oxybutynin Chloride | Oxybutynin chloride 5 mg/1 | TabletOral | A-S Medication Solutions | 50090-8078 | 50090-8078-0050090-8078-0150090-8078-03 |
| Oxybutynin Chloride | Oxybutynin chloride 5 mg/1 | TabletOral | American Health Packaging | 60687-899 | 60687-0899-01 |
| Oxybutynin Chloride | Oxybutynin chloride 2.5 mg/1 | TabletOral | Strides Pharma Science Limited | 64380-190 | 64380-0190-01 |
| Oxybutynin Chloride | Oxybutynin chloride 15 mg/1 | Tablet, Extended releaseOral | Coupler LLC | 67046-1600 | 67046-1600-03 |
| Oxybutynin Chloride | Oxybutynin chloride 5 mg/1 | Tablet, Extended releaseOral | Coupler LLC | 67046-1599 | 67046-1599-03 |
Other NDCs under ANDA 210125
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Oxybutynin Chloride | Oxybutynin chloride 5 mg/1 | TabletOral | TruPharma LLC | 52817-260 |
| Oxybutynin Chloride | Oxybutynin chloride 2.5 mg/1 | TabletOral | TruPharma LLC | 52817-261 |